Hopman Mark's Form 4 filing
Beta Bionics, Inc. (BBNX) · filed Mar 16, 2026
- Accession no.
- 0002048497-26-000004
- Filed
- Mar 16, 2026
- Trade date
- Dec 2-4, 2025
- Filing delay
- 104 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $88.3K. It was filed 104 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hopman MarkCIK 0002048497 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | SSaleDisposed | −856 | $29.34 | −$25,115.04 | 138,277 | Direct | |
| Dec 4, 2025 | Common Stock | SSaleDisposed | −2,061 | $30.66 | −$63,190.26 | 136,216 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.